PAYOR CONSIDERATIONS

Urinary tract infections (UTIs) incur significant health costs each year, and the current standard of care doesn’t adequately address the problem. Guidance® UTI is a breakthrough test that allows for the rapid treatment of UTIs for improved outcomes.

COST OF URINARY TRACT INFECTIONS

The societal costs for UTIs, including health care costs and missed work time, is approximately $3.5 billion per year.10 Without efficacious diagnostic tests, ineffective antibiotics will continue to lead to more resistant microorganisms.
COST FOR HEALTHCARE SYSTEM

UTIs are responsible for

10.5 million

office visits per year11 and are also the reason for

3.1 million

ER visits per year 12

Are the

4th

leading cause of hospitalization for Medicare patients with

200,000

hospitalizations annually13

Approximately

16.7%

of people with UTIs are admitted to the hospital, and of those

16.4%

have a readmission within 30 days14

COST TO HUMANITY

Up to 1/3 of infections illustrate resistance to an antibiotic15

According to the CDC, antibiotic resistance gives rise to at least

2 million infections

and

23,000 deaths/year16

BYPASS CHALLENGES AND ARRIVE AT SOLUTIONS QUICKLY

Guidance® UTI empowers health systems to overcome challenges associated with the current standards of care to rapidly detect and treat UTIs, resulting in a 13.7% decrease in hospital admissions.17

Traditional urine culture misses up to 22% of all UTI-positive patients.1

Guidance UTI detects 33% more organisms than culture, covering the most relevant causes of UTIs for a more accurate diagnosis.

Genotype testing alone only reports on the genetic potential to develop resistance to antibiotics, which is not enough information to guide effective treatment.

Guidance UTI is the only test that goes beyond genotype testing by including patented Pooled Antibiotic Susceptibility Testing (P-AST)™. It determines treatments that will be effective against the pool of organisms as they grow and interact in the presence of antibiotics.

Delayed personalized treatment happens consistently with traditional culture methods taking up to three days or more to return results.

Guidance UTI delivers results within 48 hours of a sample reaching the lab, for fast, personalized treatment that advances patient outcomes and antibiotic stewardship.

ABOUT PATHNOSTICS

Our mission is to pioneer a better future for physicians, patients and humanity with transformative solutions that conquer diagnostic and therapeutic dilemmas.
We introduced our patented Guidance UTI test in 2016 with the vision to guide physicians in selecting the right targeted treatment to improve both health system and patient outcomes.

LICENSES AND ACCREDITATIONS

CAP (College of American Pathologists):
7541770

CLIA (Clinical Laboratory Improvement Amendments of 1988): 05D2024468

State of California Department of Public Health: CLF00340926

New York State Department of Health PFI:
8593

Florida Agency for Health Care Administration:
800026684

Business License:
BL037033